Review: taking Propranolol hydrochloride and Adderall together


Summary

Drug interactions are reported among people who take Propranolol hydrochloride and Adderall together. This review analyzes the effectiveness and drug interactions between Propranolol hydrochloride and Adderall. It is created by eHealthMe based on reports of 219 people who take the same drugs from FDA and social media, and is updated regularly.

You are not alone

Join a support group for people who take Propranolol hydrochloride and Adderall >>>

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Propranolol Hydrochloride

Propranolol hydrochloride has active ingredients of propranolol hydrochloride. It is often used in migraine. (latest outcomes from Propranolol hydrochloride 3,246 users)

Adderall

Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. (latest outcomes from Adderall 17,000 users)

On Jul, 27, 2016

219 people who take Propranolol Hydrochloride, Adderall are studied.


Number of reports submitted per year:

Propranolol hydrochloride and Adderall drug interactions.

Drug effectiveness over time:

Propranolol Hydrochloride:
  • < 1 month: 14.0% - (1 of 7 people)
  • 1 - 6 months: 39.0% - (9 of 23 people)
  • 6 - 12 months: 44.0% - (8 of 18 people)
  • 1 - 2 years: 55.0% - (5 of 9 people)
  • 2 - 5 years: 85.0% - (6 of 7 people)
  • 5 - 10 years: 28.0% - (2 of 7 people)
  • 10+ years: 25.0% - (2 of 8 people)
  • not specified: 25.0% - (1 of 4 people)
Adderall:
  • < 1 month: 0.0% - (0 of 11 people)
  • 1 - 6 months: 28.0% - (4 of 14 people)
  • 6 - 12 months: 68.0% - (11 of 16 people)
  • 1 - 2 years: 70.0% - (12 of 17 people)
  • 2 - 5 years: 61.0% - (8 of 13 people)
  • 5 - 10 years: 62.0% - (5 of 8 people)
  • 10+ years: 71.0% - (5 of 7 people)
  • not specified: 50.0% - (2 of 4 people)

Drug effectiveness by gender:

Propranolol Hydrochloride:
  • female: 44.0% - (27 of 61 people)
  • male: 31.0% - (7 of 22 people)
Adderall:
  • female: 53.0% - (36 of 67 people)
  • male: 47.0% - (11 of 23 people)

Drug effectiveness by age:

Propranolol Hydrochloride:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 44.0% - (4 of 9 people)
  • 20-29: 29.0% - (7 of 24 people)
  • 30-39: 52.0% - (11 of 21 people)
  • 40-49: 36.0% - (7 of 19 people)
  • 50-59: 57.0% - (4 of 7 people)
  • 60+: 33.0% - (1 of 3 people)
Adderall:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 44.0% - (4 of 9 people)
  • 20-29: 74.0% - (20 of 27 people)
  • 30-39: 40.0% - (10 of 25 people)
  • 40-49: 52.0% - (10 of 19 people)
  • 50-59: 28.0% - (2 of 7 people)
  • 60+: 33.0% - (1 of 3 people)

Most common drug interactions over time *:

< 1 month:
  • abnormal weight gain
  • acne
  • dizziness
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • itching scar
  • muscle stiffness
  • palpitations
  • palpitations aggravated
  • sweating increased
  • water retention
1 - 6 months:
  • tmj disorders
  • migraine
  • difficulty initiating urination
  • insomnia
  • anxiety disorder
  • chronic pain
  • constipation aggravated
  • depression
  • edema
  • fatigue
6 - 12 months:
  • oculogyric crisis
  • chest pain
  • facial pain
  • lack of strength, muscle weakness, weakness
  • muscle twitching
  • nervousness
  • numbness and tingling
  • rapid heart beat
  • restlessness
  • back pain
1 - 2 years:
  • anger
  • addicted to drugs
  • confusion
  • confusion aggravated
  • depression
  • depression suicidal
  • discharge from breasts
  • emotional distress
  • fatigue
  • fatigue - chronic
2 - 5 years:
  • anxiety
  • arrhythmia
  • bipolar
  • chronic gouty arthritis
  • depression
  • diabetes mellitus
  • high blood pressure
  • seroma
  • temperature regulation disorder
  • type 2 diabetes mellitus
5 - 10 years:
  • rapid heart beat
  • restlessness
  • back pain
  • high potassium
  • chest pain
  • facial pain
  • lack of strength, muscle weakness, weakness
  • muscle twitching
  • nervousness
  • numbness and tingling
10+ years:
  • anorgasmia
  • nausea and vomiting
  • palpitations
  • swelling face
not specified:
  • depression
  • anxiety
  • insomnia
  • pain
  • pulmonary embolism
  • tremor
  • hypoaesthesia
  • deep vein thrombosis
  • nausea
  • constipation

Most common drug interactions by gender *:

female:
  • anxiety
  • depression
  • insomnia
  • pain
  • pulmonary embolism
  • hypoaesthesia
  • deep vein thrombosis
  • constipation
  • back pain
  • hypotension
male:
  • depression
  • mood swings
  • hyperhidrosis
  • insomnia
  • tremor
  • nausea
  • drug withdrawal syndrome
  • anger
  • panic attack
  • headache

Most common drug interactions by age *:

10-19:
  • alanine aminotransferase increased
  • blood alkaline phosphatase increased
  • bronchopulmonary aspergillosis
  • cardiomegaly
  • cholelithiasis
  • cns ventriculitis
  • convulsion
  • encephalopathy
  • fall
  • gamma-glutamyltransferase increased
20-29:
  • oculogyric crisis
  • depression
  • gallbladder injury
  • aggression
  • deep vein thrombosis
  • injury
  • insomnia
  • pain
  • pulmonary embolism
  • tmj disorders
30-39:
  • bone marrow disorder
  • livedo reticularis
  • pain
  • systemic lupus erythematosus
  • choking sensation
  • hypoaesthesia
  • intervertebral disc degeneration
  • migraine
  • palpitations
  • thyroid disorder
40-49:
  • depression
  • insomnia
  • pulmonary embolism
  • anxiety
  • fear of death
  • urine output decreased
  • deep vein thrombosis
  • haematoma
  • atelectasis
  • cervical cyst
50-59:
  • tremor
  • depression
  • insomnia
  • mania
  • anger
  • mood swings
  • bone density decreased
  • dyspnoea
  • hyperhidrosis
  • agitation
60+:
  • dizziness
  • anxiety
  • clostridial infection
  • hyperhidrosis
  • insomnia
  • loss of consciousness
  • nausea
  • rash generalised
  • thirst
  • abdominal pain

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Propranolol hydrochloride and Adderall?

Can you answer these questions?

More questions for: Propranolol hydrochloride, Adderall

You may be interested in these reviews

More reviews for: Propranolol hydrochloride, Adderall

On eHealthMe, Propranolol hydrochloride (propranolol hydrochloride) is often used to treat migraine. Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) is often used to treat attention deficit hyperactivity disorder. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.